Q2 2020 Holdings
Filed 2020-08-14 | 87 holdings | $38.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $10.4M | 762,666 | 27.1% |
| Arcturus Therapeutics Hldg I(ARCT) | COM | 03969T109 | $7.0M | 149,017 | 18.2% |
| Atricure Inc(ATRC) | COM | 04963C209 | $6.0M | 133,229 | 15.7% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $3.5M | 744,051 | 9.3% |
| Alector Inc(ALEC) | COM | 014442107 | $3.4M | 140,000 | 9.0% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $2.1M | 14,237 | 5.5% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $1.8M | 72,100 | 4.7% |
| Accuray Inc(ARAY) | COM | 004397105 | $1.4M | 674,300 | 3.6% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $1.3M | 184,850 | 3.3% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $1.0M | 64,235 | 2.7% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $61.0K | 13,680,554 | 0.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $51.0K | 6,100 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $17.8K | 228,089 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $16.8K | 490,861 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $15.4K | 245,142 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $11.5K | 454,236 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $8.9K | 73,208 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $8.9K | 250,905 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $8.8K | 44,375 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $8.6K | 21,138 | 0.0% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $7.5K | 1,237,400 | 0.0% |
| Ishares TR Nasdaq Biotech(IBB) | ETF | 464287556 | $7.5K | 54,900 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $6.9K | 165,306 | 0.0% |
| Applied Genetic Technol Corp(2GT) | COM | 03820J100 | $6.4K | 1,160,878 | 0.0% |
| Biohaven Pharmaceuticals Hold(BHVN) | COM | G11196105 | $6.4K | 87,600 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $6.3K | 371,033 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $6.3K | 270,163 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $5.3K | 360,000 | 0.0% |
| Compugen LTD(CGEN) | ORD | M25722105 | $5.2K | 343,046 | 0.0% |
| Constellation Pharmaceutical(CNST) | COM | 210373106 | $5.1K | 170,942 | 0.0% |
| Luminex Corp | COM | 55027E102 | $5.0K | 154,091 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $4.8K | 294,260 | 0.0% |
| Cardiovascular Systems Inc(CSIIEUR) | COM | 141619106 | $4.8K | 151,200 | 0.0% |
| Liquidia Technologies Inc(LQDA) | COM | 53635D202 | $4.6K | 550,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $4.3K | 346,535 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $4.1K | 279,440 | 0.0% |
| Affimed NV | COM | N01045108 | $3.9K | 845,000 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $3.3K | 450,900 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $3.0K | $4,000,000 | 0.0% |
| Axovant Gene Therapies LTD | COM | G0750W203 | $2.8K | 1,005,391 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COM | 48283N106 | $2.8K | 553,564 | 0.0% |
| Biotelemetry Inc(BEATEUR) | COM | 090672106 | $2.7K | 60,500 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.7K | 222,452 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $2.5K | 21,893 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $1.8K | 30,273 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $1.8K | 357,500 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $1.7K | 469,135 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $1.6K | 126,261 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $1.5K | 23,210 | 0.0% |
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $1.5K | 320,542 | 0.0% |